Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. Its programs include TN-201, TN-401, and TN-301. The company was ...
CHICAGO--(BUSINESS WIRE)--Adeptia, a leader in B2B data integration and business data exchange, today announced a $65 million strategic growth investment round led by PSG, a leading growth equity firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback